Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 167
Filtrar
1.
Lett Appl Microbiol ; 72(1): 36-40, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-32964486

RESUMEN

Campylobacter spp. is the leading cause of bacterial gastroenteritis worldwide and poultry are the primary reservoir. The aim of this study was to investigate the survival and/or growth of Campylobacter jejuni NCTC 11168 in broiler digestate prepared from commercial starter, grower and finisher feed formulations. Bolton broth and digestates were prepared, inoculated with C. jejuni NCTC 11168 (approximately 3 log10 CFU per ml) and incubated under microaerobic conditions at 42°C for 24 h. Samples were taken at t = 0 (immediately after inoculation) and every 3 h thereafter, serially diluted and plated onto mCCDA. Campylobacter jejuni grew as expected in Bolton broth (control) reaching the early stationary phase after approximately 15 h. In contrast, although bacterial concentrations were maintained for at least 9 h, none of the feed digestates supported the growth of C. jejuni, which were not detected after 15 h. It is suggested that the nutrients available in the feed digestates are not enough to support C. jejuni growth and that additional factors may be at play in the avian gastrointestinal tract.


Asunto(s)
Alimentación Animal/microbiología , Infecciones por Campylobacter/microbiología , Campylobacter jejuni/crecimiento & desarrollo , Pollos/microbiología , Reservorios de Enfermedades/microbiología , Gastroenteritis/microbiología , Enfermedades de las Aves de Corral/microbiología , Animales , Infecciones por Campylobacter/epidemiología , Gastroenteritis/epidemiología , Humanos
2.
Physiotherapy ; 109: 111-120, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-31493863

RESUMEN

OBJECTIVES: This study aimed to establish and compare current physiotherapy management of GTPS in Australia, New Zealand (NZ) and Ireland. DESIGN: Cross-sectional observational survey of physiotherapists. METHODS: An online survey was distributed to registered musculoskeletal physiotherapists in Australia, NZ and Ireland. Ordinal and nominal data were analysed using frequency counts or mean ranks; median and interquartile ranges were calculated for numerical data. Inter-country comparisons were made using Chi-squared analyses for nominal/ordinal data and Kruskal-Wallis tests for numerical data. Statistical significance was set at P<0.05. RESULTS/FINDINGS: Valid responses were received from 361 physiotherapists, 61% were female and 80% worked in private practice. Overall, consistency in treatment of GTPS was observed across the three countries. All physiotherapists used education and exercise (most commonly strengthening and neuromuscular control) primarily targeting the gluteal muscles. Other interventions included massage (90%), stretching (53%), range of motion (40%), thermal modalities (50%), taping (38%) and electrotherapy (25%), whilst 40% commonly recommended up to 2 to 3 corticosteroid injections per patient/per annum. Physiotherapists used pain severity scales as their primary outcome measure (79%). Single leg stance was the most common physical measure used (68%), and global rating scores or standardised physical measures were less commonly used. CONCLUSION: This international survey established the physiotherapy management of GTPS. Education used in conjunction with exercise is in line with current evidence, but a proportion of clinicians use adjunct treatments without clear rationale or supporting evidence. Results indicate the need to further define optimal management of GTPS using robust methodologies such as randomised controlled trials.


Asunto(s)
Bursitis/terapia , Fémur , Manejo del Dolor/métodos , Modalidades de Fisioterapia , Tendinopatía/terapia , Adulto , Australia , Estudios Transversales , Femenino , Humanos , Irlanda , Masculino , Persona de Mediana Edad , Nueva Zelanda , Dimensión del Dolor , Encuestas y Cuestionarios
3.
Ir J Psychol Med ; 36(4): 259-263, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31747990

RESUMEN

BACKGROUND: Clozapine is an atypical antipsychotic agent used primarily in the management of treatment-resistant schizophrenia. Previous studies have demonstrated clozapine's superior efficacy over other antipsychotic medications in treating this population of patients. The aim of this study was to assess if the number of hospital admissions and days spent in hospital reduced with the initiation of clozapine, compared with when the same sample of patients were prescribed other antipsychotics prior to clozapine initiation. METHOD: A mirror-image study design was adopted. In this case the intervention under study was the initiation of clozapine. Information was collected retrospectively from the charts of patients attending the University Hospital Galway clozapine clinic. The number of admissions and number of hospital days were collected for each patient over the 3 years before and after clozapine initiation. Wilcoxon's signed-rank test was used to test for statistical significance. RESULTS: The total sample size comprised of 62 patients, of which the majority were male (74.2%) and had a diagnosis of schizophrenia (82.3%). The mean dose of clozapine was 417 mg, and mean age of the sample was 38 years. Mean number of hospital admissions reduced from 2.8 to 0.8 (p<0.0001) following initiation of clozapine. Mean number of days spent in hospital reduced from 116.4 to 17.1 (p<0.0001). CONCLUSION: After initiation of clozapine treatment, patients experience a substantial reduction in number of hospital admissions and number of days spent in hospital when compared with a similar period prior to clozapine initiation.


Asunto(s)
Antipsicóticos/efectos adversos , Clozapina/efectos adversos , Sustitución de Medicamentos/efectos adversos , Hospitalización/estadística & datos numéricos , Adulto , Antipsicóticos/uso terapéutico , Clozapina/uso terapéutico , Resistencia a Medicamentos , Femenino , Hospitalización/tendencias , Hospitales Psiquiátricos/estadística & datos numéricos , Hospitales Psiquiátricos/tendencias , Humanos , Masculino , Estudios Retrospectivos , Esquizofrenia/diagnóstico , Esquizofrenia/tratamiento farmacológico , Resultado del Tratamiento
4.
Musculoskelet Sci Pract ; 43: 122-126, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-31285186

RESUMEN

PURPOSE: To evaluate how physiotherapists across three countries (Australia, New Zealand (NZ) and Ireland) diagnose greater trochanteric pain syndrome (GTPS) using clinical tests and imaging findings, and how physiotherapists update their knowledge regarding GTPS. DESIGN: Cross-sectional observational study of physiotherapists. METHODS: An online survey was distributed to registered physiotherapists in Australia, NZ and Ireland. Ordinal and nominal data were analysed using frequency counts or mean ranks; medians and interquartile ranges were calculated for numerical data. Comparisons between the three countries were made using Chi-squared analyses for nominal/ordinal data and Kruskal Wallis tests for numerical data. Statistical significance was set at p < 0.05. RESULTS/FINDINGS: Valid responses were received from 361 physiotherapists; 61% were female and 79.8% worked in private practice. Most respondents were very confident in diagnosing GTPS (67.9%) and incorporated a range of symptoms and tests, including validated tests, in their diagnosis. However, many physiotherapists were not commonly using some available validated diagnostic tests (e.g. FABER and FADER-R). Approximately 30% of physiotherapists used imaging to inform assessment, with ultrasound being most preferred. Physiotherapists rated hands-on experience as most valuable for updating their knowledge of GTPS, followed by courses. CONCLUSION: While most clinicians appear to be using current evidence in their assessment of patients with GTPS, a proportion use suboptimal methods and/or a limited range of diagnostic tests, suggesting that despite their confidence in diagnosis, further knowledge translation may be required. Future research should determine the best methods of facilitating knowledge acquisition and translation of research into practice.


Asunto(s)
Bursitis/diagnóstico , Bursitis/rehabilitación , Fémur , Conocimientos, Actitudes y Práctica en Salud , Fisioterapeutas , Modalidades de Fisioterapia , Tendinopatía/diagnóstico , Tendinopatía/rehabilitación , Adulto , Australia , Estudios Transversales , Femenino , Humanos , Irlanda , Masculino , Nueva Zelanda , Manejo del Dolor , Dimensión del Dolor , Encuestas y Cuestionarios , Síndrome , Investigación Biomédica Traslacional
5.
Int J Drug Policy ; 64: 5-12, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30513421

RESUMEN

BACKGROUND: Little is known about the prevalence and determinants of drug use among men who have sex with men (MSM) in Ireland. The aims of this study were to measure the prevalence of recreational drug use among MSM in a national sample, and to identify sub-groups of MSM who may benefit from targeted preventive interventions. METHODS: The MSM Internet Survey Ireland (MISI) 2015 was a community-recruited, nationally-promoted, self-completed online survey for MSM. MISI 2015 included standardised questions on recreational drugs, poppers, and drugs associated with chemsex (i.e. crystal methamphetamine, GBL/GHB, mephedrone, ketamine). Multivariable-adjusted logistic regression was used to identify factors associated with use of these substances. RESULTS: In the previous year, 36% of MSM used recreational drugs, 33% used poppers, and 7% used drugs associated with chemsex. Five percent were diagnosed HIV-positive. Recreational drug users were significantly younger than non-users (median = 27 vs. 32 years; p < 0.001); popper users were significantly older than non-users (median = 34 vs. 28 years; p < 0.001). The odds of recreational drug use were higher among MSM diagnosed HIV-positive (vs. never tested; AOR 2.27, 95%CI 1.39-3.70). Use of poppers, and use of drugs associated with chemsex, were also higher among MSM diagnosed HIV-positive (vs. never tested; AOR 3.77, 95%CI 2.41-5.90, and AOR 5.87, 95%CI 3.08-11.18 respectively). CONCLUSIONS: The prevalence of recreational drug use is higher among MSM than in the general population in Ireland, and it is particularly high among MSM diagnosed HIV-positive. Targeted harm reduction messages and preventive interventions are warranted to complement population-based approaches to reducing drug use in this population.


Asunto(s)
Consumidores de Drogas/estadística & datos numéricos , Infecciones por VIH/epidemiología , Homosexualidad Masculina/estadística & datos numéricos , Adolescente , Adulto , Estudios Transversales , Humanos , Drogas Ilícitas , Irlanda/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Conducta Sexual/estadística & datos numéricos , Trastornos Relacionados con Sustancias/epidemiología , Encuestas y Cuestionarios , Personas Transgénero , Sexo Inseguro/estadística & datos numéricos , Adulto Joven
6.
Physiotherapy ; 105(1): 126-133, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30343873

RESUMEN

OBJECTIVE: Early mobilisation is in integral component of postoperative recovery following complex surgical procedures such as oesophageal cancer resections, however evidence to guide early mobilisation protocols in critical care settings is limited. Furthermore, little is known about actual mobilisation levels postoperatively. This study quantified postoperative mobilisation post- oesophagectomy and investigated barriers to mobility. DESIGN: Prospective observational study. SETTING: Postoperative critical care setting in a tertiary care referral centre for oesophagectomy. PARTICIPANTS: Thirty participants (mean age 65 (SD 7) years, n=19 males) scheduled for oesophagectomy. MAIN OUTCOME MEASURES: The primary outcome, postoperative physical activity, was measured objectively using the Actigraph GT3X+. Medical records were examined for a range of outcomes including medical status, pain scores and physiotherapy comments to identify factors which may have influenced mobility. RESULTS: During postoperative day (POD) 1-5, participants spent the majority of time (>96%) sedentary. Participation in light intensity activity was low but did increase daily from a median of 12 (IQR 19) minutes/day on POD1 to a median of 53 (IQR 73.25) minutes/day on POD5 p<0.001), with a corresponding increase in daily step count. Haemodynamic instability was the most common reason reported by physiotherapists for either not attempting mobility or limiting postoperative mobilisation levels. CONCLUSIONS: These data demonstrate that despite daily physiotherapy, there are multiple challenges to postoperative mobilisation. Haemodynamic instability, likely related to thoracic epidurals, was the key limitation to early mobilisation. Goal-directed mobilisation in collaboration with the multidisciplinary team may play a considerable role in overcoming modifiable barriers to postoperative mobilisation.


Asunto(s)
Ambulación Precoz/métodos , Neoplasias Esofágicas/cirugía , Esofagectomía/rehabilitación , Modalidades de Fisioterapia , Actigrafía , Anciano , Ejercicio Físico , Femenino , Humanos , Tiempo de Internación , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Cuidados Posoperatorios/métodos , Complicaciones Posoperatorias/epidemiología , Estudios Prospectivos , Factores de Riesgo
7.
BMC Infect Dis ; 18(1): 225, 2018 05 16.
Artículo en Inglés | MEDLINE | ID: mdl-29769028

RESUMEN

BACKGROUND: Antimicrobial stewardship (AMS) interventions largely target inpatient antimicrobial prescribing. Literature on appropriateness of antimicrobials prescribed at the interface between hospital and the community is minimal. This study was designed to assess the appropriateness of antimicrobials prescribed on hospital discharge and evaluate the impact of AMS interventions. METHODS: Patients with discharge medications processed by the pharmacy were identified using a computerized pharmacy medication tracker over a four week period. The antimicrobials prescribed on discharge were assessed independently for appropriateness of antimicrobial choice, dose, frequency and duration. Data on various AMS interventions was collected. Univariate followed by multivariate logistic regression (MVLR) analysis was performed using SPSS V 23 (IBM, California). RESULTS: A total of 892 discharge prescriptions were processed by the pharmacy department, 236 of which contained antibiotic prescriptions. Of these, 74% were appropriate for antimicrobial choice, 64% for dose, 64% for frequency and 21% for duration. In particular, 71% of patients received a course in excess of Therapeutic Guidelines-Australia(TG-A) recommended length of treatment. On univariate analysis, discharge antimicrobial prescriptions were more likely to be appropriate for antimicrobial choice, frequency and duration; appropriate microbiological specimens were more likely to be taken and targeted therapy more likely to be given when the AMS team was involved. On MVLR, appropriateness with antimicrobial dosing frequency [OR 5.6(1.9-19.2)], microbiological specimens [OR 4.3(1.6-11.6)] and receipt of targeted therapy [OR 2.8(1.8-6.2)] with AMS involvement remained significant. CONCLUSIONS: A large discrepancy exists between antimicrobial regimens prescribed on hospital discharge and those recommended in consensus guidelines, particularly concerning duration of treatment. While AMS interventions are well established for improving antimicrobial prescribing in hospital inpatients, the hospital-community interface remains a challenge in terms of antimicrobial prescribing and exposes patients to potential harm. There is a clear need for AMS interventions to extend to antimicrobial therapy prescribed on discharge.


Asunto(s)
Antiinfecciosos/uso terapéutico , Programas de Optimización del Uso de los Antimicrobianos/organización & administración , Programas de Optimización del Uso de los Antimicrobianos/normas , Alta del Paciente/normas , Pautas de la Práctica en Medicina/normas , Programas de Optimización del Uso de los Antimicrobianos/métodos , Australia/epidemiología , Hospitales/normas , Hospitales/estadística & datos numéricos , Humanos , Alta del Paciente/estadística & datos numéricos , Rol del Médico , Pautas de la Práctica en Medicina/organización & administración
8.
Epidemiol Infect ; 146(6): 705-711, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29582721

RESUMEN

Hepatitis A infection results in a spectrum of illness from asymptomatic disease to severe fulminant hepatitis. Since 2000, <50 cases have been reported annually in Ireland. We report on an outbreak of hepatitis A associated with a childcare facility(CCF) in 2015 in Ireland. Between January and July 2015, 12 outbreak-associated symptomatic hepatitis A cases were identified, including one delayed, retrospective diagnosis. Seven (58%) cases were adults, eight (67%) were male, six of the adults required hospitalisation. All 12 cases were confirmed on serology and the four cases that were genotyped were identical on phylogenetic analysis. Potential environmental exposures and hygiene practices at the CCF were investigated. Outbreak control measures included the provision of: hepatitis A information, infection prevention advice, hepatitis A vaccination to 554 CCF contacts, and voluntary closure of the CCF for deep-cleaning and staff education. From a healthcare perspective1, outbreak control costs were in excess of €45 000. This outbreak illustrates the considerable adult morbidity that can occur in hepatitis A outbreaks, highlights the challenges in controlling a large CCF-associated outbreak and the importance of early recognition by clinicians of hepatitis A.


Asunto(s)
Brotes de Enfermedades , Hepatitis A/epidemiología , Adolescente , Adulto , Niño , Preescolar , Femenino , Genotipo , Virus de la Hepatitis A/clasificación , Virus de la Hepatitis A/genética , Humanos , Lactante , Irlanda/epidemiología , Masculino , Persona de Mediana Edad , Filogenia , Estudios Retrospectivos , Pruebas Serológicas
9.
BMC Pregnancy Childbirth ; 16(1): 184, 2016 07 25.
Artículo en Inglés | MEDLINE | ID: mdl-27457248

RESUMEN

BACKGROUND: Maternal morbidity refers to pregnancy-related complications, ranging in severity from acute to chronic. In Ireland one in 210 maternities will experience a severe morbidity. Yet, how women internalize their experience of morbidity has gone largely unexplored. This study aimed to explore women's experiences of maternal morbidity. METHODS: A qualitative semi-structured interview format was utilized. Purposive sampling was used to recruit 14 women with a maternal morbidity before, during or after birth; nine women were diagnosed with one morbidity including hypertensive disorders, haemorrhage, placenta praevia and gestational diabetes whereas five women were diagnosed with two or more morbidities. Thematic analysis was employed as the analytic strategy. RESULTS: Four superordinate themes were identified: powerlessness, morbidity management, morbidity treatment and socio-behavioural responses to morbidities. Women were accepting of the uncontrollable nature of the adverse outcome experienced. While being treated for trauma, women were satisfied to relinquish their autonomy to ensure the safety of themselves and their babies. However, these events were debilitating. Women's inability to control their own bodies, as a result of the morbidity, contributed to high levels of frustration and anxiety. Morbidities impacted greatly on women's quality of life and sometimes these effects persisted for a prolonged period after delivery. Women felt that they were provided very little information on the practicalities of living with their condition; many were uncertain how to manage their morbidities in the home setting. CONCLUSION: Healthcare providers should ensure that women who experience a maternal morbidity are fully debriefed and have sufficient information on the morbidity including ongoing care and expectations prior to discharge.


Asunto(s)
Satisfacción del Paciente , Complicaciones del Embarazo/psicología , Complicaciones del Embarazo/terapia , Trauma Psicológico/etiología , Ansiedad/etiología , Femenino , Frustación , Humanos , Entrevistas como Asunto , Irlanda , Educación del Paciente como Asunto , Autonomía Personal , Embarazo , Investigación Cualitativa , Calidad de Vida
10.
Am J Physiol Gastrointest Liver Physiol ; 310(1): G13-25, 2016 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-26514775

RESUMEN

We tested whether the T helper (Th) type 2 (Th2) cell agonist and allergenic ligand IL-33 was associated with eosinophilic esophagitis (EoE) development in a pediatric cohort and whether IL-33 protein could induce disease symptoms in mice. Biopsies from EoE patients or controls were used to measure IL-33 mRNA and protein expression. Increased expression of IL-33 mRNA was found in the esophageal mucosa in EoE. IL-33 protein was detected in cells negative for CD45, mast cells, and epithelial cell markers near blood vessels. Circulating levels of IL-33 were not increased. The time course for IL-33 gene expression was quantified in an established Aspergillus fumigatus allergen mouse model of EoE. Because IL-33 induction was transient in this model and chronicity of IL-33 expression has been demonstrated in humans, naive mice were treated with recombinant IL-33 for 1 wk and esophageal pathology was evaluated. IL-33 application produced changes consistent with phenotypically early EoE, including transmural eosinophilia, mucosal hyperproliferation, and upregulation of eosinophilic genes and chemokines. Th2 cytokines, including IL-13, along with innate lymphoid cell group 2, Th1/17, and M2 macrophage marker genes, were increased after IL-33 application. IL-33-induced eosinophilia was ablated in IL-13 null mice. In addition, IL-33 induced a profound inhibition of the regulatory T cell gene signature. We conclude that IL-33 gene expression is associated with pediatric EoE development and that application of recombinant protein in mice phenocopies the early clinical phase of the human disease in an IL-13-dependent manner. IL-33 inhibition of esophageal regulatory T cell function may induce loss of antigenic tolerance, thereby providing a mechanistic rationale for EoE development.


Asunto(s)
Esofagitis Eosinofílica/inducido químicamente , Esofagitis Eosinofílica/metabolismo , Esófago/metabolismo , Mediadores de Inflamación/metabolismo , Interleucina-33/metabolismo , Inmunidad Adaptativa , Adolescente , Animales , Aspergillus fumigatus/patogenicidad , Biopsia , Estudios de Casos y Controles , Proliferación Celular , Quimiocina CCL26 , Quimiocinas CC/metabolismo , Niño , Preescolar , Modelos Animales de Enfermedad , Células Endoteliales/inmunología , Células Endoteliales/metabolismo , Esofagitis Eosinofílica/genética , Esofagitis Eosinofílica/inmunología , Esofagitis Eosinofílica/microbiología , Esofagitis Eosinofílica/patología , Esófago/inmunología , Esófago/microbiología , Esófago/patología , Humanos , Tolerancia Inmunológica , Inmunidad Innata , Interleucina-13/deficiencia , Interleucina-13/genética , Interleucina-33/genética , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones Endogámicos BALB C , Ratones Noqueados , Fenotipo , ARN Mensajero/metabolismo , Linfocitos T Colaboradores-Inductores/inmunología , Linfocitos T Colaboradores-Inductores/metabolismo , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/metabolismo , Factores de Tiempo , Regulación hacia Arriba
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA